IS
Therapeutic Areas
NurExone Biologic Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ExoPTEN | Acute Spinal Cord Injury | Preclinical |
| ExoPTEN‑Glaucoma | Acute Glaucoma | Preclinical |
Leadership Team at NurExone Biologic
LS
Lior Shaltiel, PhD
Chief Executive Officer & Director
EO
Eran Ovadya, MBA
Chief Financial Officer
TK
Tali Kizhner, PhD
R&D Director
RP
Ram Petter, PhD, MBA
Head of Operations
YD
Yoram Drucker
Co‑Founder, Chairman & VP Strategic Development
EG
Eyal Gabbai
Director